Study to validate the questionnaire called IDSIQ™ in patients suffering from difficulties to sleep.

Registry ID

EUCTR2016-004259-59

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Idorsia Pharmaceuticals Ltd

Start date

2016-12-20

Completion date

2017-06-12

Last update

2026-08-16

Conditions

• Insomnia disorder

Summary

The main study objective is to assess the content validity and the psychometric characteristics of the IDSIQ™ and evaluate its appropriateness for use in the population of patients with insomnia disorder.

Locations

• , , Germany

View on source registry